Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: an International Oncology Study Group (IOSG) phase II protocol (Q33331536)
scientific article
Language:
(P31) (Q13442814)
(P304) 125-130
(P407) (Q1860)
(P433) 3
(P478) 63
(P577) Wednesday, March 1, 2000
(P921) (Q422252)
(Q467635)
(Q18936)
(Q418817)
(P1433) (Q4744246)
(P1476) "Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: an International Oncology Study Group (IOSG) phase II protocol" (language: en)
(P2093) Giles FJ
Wickham NR
Rapoport BL
Somlo G
Lim SW
Shan J
Lynott AM
(P2860) (Q54198270)
(Q36466691)
(Q44907894)
other details